Client: Morgan, Lewis & Bockius LLP (USA) — international law firm
Trademark Owner: Geron Corporation (USA) — a biopharmaceutical company focused on the development of telomerase inhibitors for cancer therapy
Legal Support Area: International trademark registration (Madrid System)
Project Summary
In October 2022, Polikarpov Law Firm acted on behalf of Morgan Lewis, representing Geron Corporation in overcoming a provisional refusal issued by the Ukrainian IP Office regarding the international registration of the trademark TELRYZA.
Our team prepared a detailed legal response, successfully convincing the Office to reverse its refusal and proceed with registration.
Client’s Goals
- Overcome the provisional refusal and secure the registration of TELRYZA in Ukraine
- Protect the brand for a pharmaceutical product under the Madrid System
- Align Ukrainian protection with Geron Corporation’s global IP portfolio
Case Complexity
- Responding to a formal refusal within limited procedural timelines
- Drafting a persuasive legal argument grounded in Ukrainian trademark law
- Coordinating with international counsel and understanding medical regulatory context
Polikarpov Law Firm’s Actions
- Reviewed the grounds for refusal and identified procedural inconsistencies
- Drafted and submitted a comprehensive legal response
- Coordinated with Morgan Lewis on legal and communication strategy
- Followed up on the application status until a favorable decision was issued
Lawyers
Anton Polikarpov — Managing Partner, led the response strategy and client coordination
Anastasiia Shevchuk — Senior Associate, prepared the legal submission and managed correspondence
Result
The Ukrainian IP Office cancelled the refusal and registered the trademark TELRYZA under the international registration. This secured Geron Corporation’s trademark rights in Ukraine and ensured protection of its oncology-related pharmaceutical brand in this jurisdiction.
